CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension [Phase 3]
Summary
A Phase 3 trial evaluating macitentan in Japanese pediatric participants with pulmonary arterial hypertension has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2025-10-21